Luc E Coffeng (Luc Coffeng)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Topics

Drug Administration

Breast Cancer Cells

Plasmodium Falciparum

Trypanosoma Cruzi

Top Venues

PLoS neglected tropical diseases

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

NPJ primary care respiratory medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Luc E Coffeng, Matthew Graham, Raiha Browning, Klodeta Kura, Peter J Diggle, Matthew Denwood, Graham F Medley, Roy M Anderson, Sake J de Vlas
Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 78 (Supplement_2) (2024)
Luc E Coffeng, Wilma A Stolk, Sake J de Vlas
Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy. Nature communications 15 (1) (2024)
Timor Faber, Luc E Coffeng, Aziz Sheikh, Irwin K Reiss, Johan P Mackenbach, Jasper V Been
Tobacco control policies and respiratory conditions among children presenting in primary care. NPJ primary care respiratory medicine 34 (1) (2024)
Luc E Coffeng, Wilma A Stolk, Sake J de Vlas
Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy. Nature communications 15 (1) (2024)
Timor Faber, Luc E Coffeng, Aziz Sheikh, Irwin K Reiss, Johan P Mackenbach, Jasper V Been
Tobacco control policies and respiratory conditions among children presenting in primary care. NPJ primary care respiratory medicine 34 (1) (2024)
Luc E Coffeng, Matthew Graham, Raiha Browning, Klodeta Kura, Peter J Diggle, Matthew Denwood, Graham F Medley, Roy M Anderson, Sake J de Vlas
Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 78 (Supplement_2) (2024)
Luc E Coffeng, Matthew Graham, Raiha Browning, Klodeta Kura, Peter J Diggle, Matthew Denwood, Graham F Medley, Roy M Anderson, Sake J de Vlas
Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 78 (Supplement_2) (2024)
Luc E Coffeng, Wilma A Stolk, Sake J de Vlas
Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy. Nature communications 15 (1) (2024)
Timor Faber, Luc E Coffeng, Aziz Sheikh, Irwin K Reiss, Johan P Mackenbach, Jasper V Been
Tobacco control policies and respiratory conditions among children presenting in primary care. NPJ primary care respiratory medicine 34 (1) (2024)
Timor Faber, Luc E Coffeng, Aziz Sheikh, Irwin K Reiss, Johan P Mackenbach, Jasper V Been
Tobacco control policies and respiratory conditions among children presenting in primary care. NPJ primary care respiratory medicine 34 (1) (2024)
Mark M Dekker, Luc E Coffeng, Frank P Pijpers, Debabrata Panja, Sake J de Vlas
Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation. eLife 12 (2023)
Mark M Dekker, Luc E Coffeng, Frank P Pijpers, Debabrata Panja, Sake J de Vlas
Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation. eLife 12 (2023)
Luc E Coffeng, Johnny Vlaminck, Piet Cools, Matthew Denwood, Marco Albonico, Shaali M Ame, Mio Ayana, Daniel Dana, Giuseppe Cringoli, Sake J de Vlas, Alan Fenwick, Michael French, Adama Kazienga, Jennifer Keiser, Stefanie Knopp, Gemechu Leta, Leonardo F Matoso, Maria P Maurelli, Antonio Montresor, Greg Mirams, Zeleke Mekonnen, Rodrigo Corrêa-Oliveira, Simone A Pinto, Laura Rinaldi, Somphou Sayasone, Peter Steinmann, Eurion Thomas, Jozef Vercruysse, Bruno Levecke
A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs-monitoring of therapeutic drug efficacy as a case study. PLoS neglected tropical diseases 17 (5) (2023)
Mariska M J Scheffer, Luc E Coffeng, James F O'Mahony
Appropriateness of strategy comparisons in cost-effectiveness analyses of infant pneumococcal vaccination: a systematic review. International journal of technology assessment in health care 39 (1) (2023)
Mark M Dekker, Luc E Coffeng, Frank P Pijpers, Debabrata Panja, Sake J de Vlas
Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation. eLife 12 (2023)
Mark M Dekker, Luc E Coffeng, Frank P Pijpers, Debabrata Panja, Sake J de Vlas
Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation. eLife 12 (2023)
Mark M Dekker, Luc E Coffeng, Frank P Pijpers, Debabrata Panja, Sake J de Vlas
Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation. eLife 12 (2023)
Adama Kazienga, Luc E Coffeng, Sake J de Vlas, Bruno Levecke
Two-stage lot quality assurance sampling framework for monitoring and evaluation of neglected tropical diseases, allowing for imperfect diagnostics and spatial heterogeneity. PLoS neglected tropical diseases 16 (4) (2022)
Jessica Clark, Wilma A Stolk, María-Gloria Basáñez, Luc E Coffeng, Zulma M Cucunubá, Matthew A Dixon, Louise Dyson, Katie Hampson, Michael Marks, Graham F Medley, Timothy M Pollington, Joaquín M Prada, Kat S Rock, Henrik Salje, Jaspreet Toor, T Deirdre Hollingsworth
How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases. Gates open research 5 (2022)
Veronica Malizia, Federica Giardina, Sake J de Vlas, Luc E Coffeng
Appropriateness of the current parasitological control target for hookworm morbidity: A statistical analysis of individual-level data. PLoS neglected tropical diseases 16 (6) (2022)
Isaie J Reuling, António M Mendes, Gerdie M de Jong, Amanda Fabra García, Helena Nunes-Cabaço, Geert-Jan van Gemert, Wouter Graumans, Luc E Coffeng, Sake J de Vlas, Annie S P Yang, Cynthia Lee, Yimin Wu, Ashley J Birkett, Christian F Ockenhouse, Rob Koelewijn, Jaap J Van Hellemond, Perry J J van Genderen, Robert W Sauerwein, Miguel Prudncio
An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria. Science translational medicine 12 (544) (2021)
Jessica Clark, Wilma A Stolk, María-Gloria Basáñez, Luc E Coffeng, Zulma M Cucunubá, Matthew A Dixon, Louise Dyson, Katie Hampson, Michael Marks, Graham F Medley, Timothy M Pollington, Joaquín M Prada, Kat S Rock, Henrik Salje, Jaspreet Toor, T Deirdre Hollingsworth
How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases. Gates open research 5 (2021)
Anneke S de Vos, Wilma A Stolk, Luc E Coffeng, Sake J de Vlas
The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages. PLoS neglected tropical diseases 15 (5) (2021)
Bruno Levecke, Luc E Coffeng, Christopher Hanna, Rachel L Pullan, Katherine M Gass
Assessment of the required performance and the development of corresponding program decision rules for neglected tropical diseases diagnostic tests: Monitoring and evaluation of soil-transmitted helminthiasis control programs as a case study. PLoS neglected tropical diseases 15 (9) (2021)
Natalie V S Vinkeles Melchers, Wilma A Stolk, Welmoed van Loon, Belén Pedrique, Roel Bakker, Michele E Murdoch, Sake J de Vlas, Luc E Coffeng
The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030. PLoS neglected tropical diseases 15 (7) (2021)
Luc E Coffeng, Epke A Le Rutte, Johanna Munoz, Emily Adams, Sake J de Vlas
Antibody and Antigen Prevalence as Indicators of Ongoing Transmission or Elimination of Visceral Leishmaniasis: A Modeling Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 72 (Suppl 3) (2021)
Federica Gugole, Luc E Coffeng, Wouter Edeling, Benjamin Sanderse, Sake J de Vlas, Daan Crommelin
Uncertainty quantification and sensitivity analysis of COVID-19 exit strategies in an individual-based transmission model. PLoS computational biology 17 (9) (2021)
João Gabriel Guimarães Luz, Amanda Gabriela de Carvalho, João Victor Leite Dias, Luis Claudio L Marciano, Sake J de Vlas, Cor Jesus Fernandes Fontes, Luc E Coffeng
Passive case detection for canine visceral leishmaniasis control in urban Brazil: Determinants of population uptake. PLoS neglected tropical diseases 15 (10) (2021)
Jaspreet Toor, Jonathan I D Hamley, Claudio Fronterre, María Soledad Castaño, Lloyd A C Chapman, Luc E Coffeng, Federica Giardina, Thomas M Lietman, Edwin Michael, Amy Pinsent, Epke A Le Rutte, T Deirdre Hollingsworth
Strengthening data collection for neglected tropical diseases: What data are needed for models to better inform tailored intervention programmes? PLoS neglected tropical diseases 15 (5) (2021)
Daniel Engelman, Michael Marks, Andrew C Steer, Abate Beshah, Gautam Biswas, Olivier Chosidow, Luc E Coffeng, Belen Lardizabal Dofitas, Wendemagegne Enbiale, Mosoka Fallah, Elkhan Gasimov, Adrian Hopkins, Julie Jacobson, John M Kaldor, Fatimata Ly, Charles D Mackenzie, Jodie McVernon, Matthew Parnaby, Merelesita Rainima-Qaniuci, Oliver Sokana, Dieudonne Sankara, Rie Yotsu, Aya Yajima, Paul T Cantey
A framework for scabies control. PLoS neglected tropical diseases 15 (9) (2021)
Luc E Coffeng, Bruno Levecke, Jan Hattendorf, Martin Walker, Matthew J Denwood
Survey Design to Monitor Drug Efficacy for the Control of Soil-Transmitted Helminthiasis and Schistosomiasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 72 (Suppl 3) (2021)
Natalie V S Vinkeles Melchers, Wilma A Stolk, Michele E Murdoch, Belén Pedrique, Marielle Kloek, Roel Bakker, Sake J de Vlas, Luc E Coffeng
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? PLoS neglected tropical diseases 15 (6) (2021)
Epke A Le Rutte, Luc E Coffeng, Stefano Malvolti, Paul M Kaye, Sake J de Vlas
The potential impact of human visceral leishmaniasis vaccines on population incidence. PLoS neglected tropical diseases 14 (7) (2020)
Tiago M de Carvalho, Eveline A M Heijnsdijk, Luc E Coffeng, Harry J de Koning
Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators. Medical decision making : an international journal of the Society for Medical Decision Making 39 (4) (2019)
Caroline A Bulstra, Epke A Le Rutte, Paritosh Malaviya, Epco C Hasker, Luc E Coffeng, Albert Picado, Om Prakash Singh, Marleen C Boelaert, Sake J de Vlas, Shyam Sundar
Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India. PLoS neglected tropical diseases 12 (12) (2018)
Luc E Coffeng, Susana Vaz Nery, Darren J Gray, Roel Bakker, Sake J de Vlas, Archie C A Clements
Predicted short and long-term impact of deworming and water, hygiene, and sanitation on transmission of soil-transmitted helminths. PLoS neglected tropical diseases 12 (12) (2018)
Anneke S de Vos, Wilma A Stolk, Sake J de Vlas, Luc E Coffeng
The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis. PLoS neglected tropical diseases 12 (10) (2018)
Luc E Coffeng, Cornelus C Hermsen, Robert W Sauerwein, Sake J de Vlas
The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection. PLoS computational biology 13 (1) (2017)